NOC chemistry for tuberculosis-further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives.
作者信息
Pieroni Marco, Lilienkampf Annamaria, Wang Yuehong, Wan Baojie, Cho Sanghyun, Franzblau Scott G, Kozikowski Alan P
机构信息
Department of Medicinal Chemistry & Pharmacognosy, University of Illinois, Chicago, IL 60612, USA.
出版信息
ChemMedChem. 2010 Oct 4;5(10):1667-72. doi: 10.1002/cmdc.201000169.
PMID:20718072
Abstract
摘要
相似文献
1
NOC chemistry for tuberculosis-further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives.用于结核病的NOC化学——抗结核异恶唑-3-羧酸酯衍生物构效关系的进一步研究
ChemMedChem. 2010 Oct 4;5(10):1667-72. doi: 10.1002/cmdc.201000169.
2
Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.作为抗分枝杆菌剂的氟化1,2,4-三唑并[1,5-a]嘧啶-6-羧酸衍生物
Arch Pharm (Weinheim). 2009 Feb;342(2):94-9. doi: 10.1002/ardp.200800113.
3
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.新型吡唑类似物作为结核分枝杆菌抑制剂的合成、生物学评价及构效关系研究：第2部分。刚性吡唑啉酮的合成。
Bioorg Med Chem. 2009 Aug 1;17(15):5716-21. doi: 10.1016/j.bmc.2009.05.058. Epub 2009 May 29.
4
Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.新型 2-酰化和 2-烷基化氨基-5-(4-(苄氧基)苯基)噻吩-3-羧酸衍生物的设计、合成与抗结核活性评价。第 1 部分。
Eur J Med Chem. 2011 Sep;46(9):3551-63. doi: 10.1016/j.ejmech.2011.05.018. Epub 2011 May 19.
5
Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.新型系列光学活性6-硝基-2,3-二氢咪唑并[2,1-b]恶唑的合成及其抗结核活性
J Med Chem. 2006 Dec 28;49(26):7854-60. doi: 10.1021/jm060957y.
6
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.5-苯基-3-异恶唑羧酸乙酯的合理设计作为结核分枝杆菌的生长抑制剂。这一系列化合物具有强大的选择性，可进一步开发成为药物。
J Med Chem. 2010 Jan 28;53(2):678-88. doi: 10.1021/jm901273n.
7
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.1,5-二芳基-2-乙基吡咯衍生物作为抗分枝杆菌剂：设计、合成与微生物评价。
Eur J Med Chem. 2009 Nov;44(11):4734-8. doi: 10.1016/j.ejmech.2009.06.005. Epub 2009 Jun 13.
8
Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.6-[1(3H)-异苯并呋喃基亚甲基]嘌呤及其类似物的合成、结构与抗分枝杆菌活性
Bioorg Med Chem. 2009 Sep 15;17(18):6512-6. doi: 10.1016/j.bmc.2009.08.012. Epub 2009 Aug 12.
9
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.从偶然发现到甲氟喹异恶唑羧酸酯类抗结核药物的理性研发
J Med Chem. 2009 Nov 26;52(22):6966-78. doi: 10.1021/jm900340a.
10
Structural requirements for the antitubercular quaternized triflupromazine pharmacophore.抗结核季铵化三氟丙嗪药效团的结构要求。
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5679-80. doi: 10.1016/j.bmcl.2012.06.095. Epub 2012 Jul 6.
引用本文的文献
1
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization.拓展抗结核 5-(2-氨基噻唑-4-基)异噁唑-3-甲酰胺的相关知识：基于骨架衍生化的新型抗结核化学型物的从头至先导优化和释放。
Eur J Med Chem. 2023 Jan 5;245(Pt 2):114916. doi: 10.1016/j.ejmech.2022.114916. Epub 2022 Nov 11.
2
Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis.挑战结核病新药研发中的类药规则
Front Microbiol. 2018 Jul 3;9:1367. doi: 10.3389/fmicb.2018.01367. eCollection 2018.
Zotero 插件